The MiniMed 780G was trialed on 39 adolescents and 118 adults with Type 1 Diabetes. Participants used the system for two 45-day periods with different blood glucose target points. The study found that …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our